AlphaGrep UK’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$369K Sell
10,090
-2,655
-21% -$96.3K 0.11% 392
2026
Q2
$451K Sell
12,745
-19,126
-60% -$565K 0.13% 274
2026
Q1
$883K Buy
31,871
+12,934
+68% +$332K 0.26% 42
2025
Q4
$411K Buy
+18,937
New +$374K 0.14% 275

Other funds holding ROIV

AlphaGrep UK's ROIV Position: Q3 2026 in Review

AlphaGrep UK reduced its Roivant Sciences (ROIV) stake by 21% in Q3 2026, selling an estimated $96.3K and leaving 10,090 shares worth $369K. The position accounts for 0.11% of the portfolio, ranked #392.

AlphaGrep UK first reported a position in ROIV in Q4 2025 and has held it in 4 quarters since. The position peaked at $883K in Q1 2026. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • AlphaGrep UK held 10,090 shares of Roivant Sciences worth $369K as of Q3 2026.
  • AlphaGrep UK sold 2,655 Roivant Sciences shares in Q3 2026, an estimated $96.3K.
  • Roivant Sciences made up 0.11% of AlphaGrep UK's portfolio in Q3 2026, its #392 holding.
  • AlphaGrep UK first reported a position in Roivant Sciences in Q4 2025 and has held it in 4 quarters since.
  • AlphaGrep UK's Roivant Sciences position peaked at $883K in Q1 2026.
  • 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.